跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RETSEVMO CAPSULES 40MG - PPB Drug Approval Details
Approvals
/
PPB
/
RETSEVMO CAPSULES 40MG
Approved
STANDARD
RETSEVMO CAPSULES 40MG
ELI LILLY ASIA, INC.
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
33ff326f6ab0bc04
Company
ELI LILLY ASIA, INC.
Type
Standard
Approval Details
Approval Id
33ff326f6ab0bc04
Product Name
RETSEVMO CAPSULES 40MG
Drug Hk Name
RETSEVMO CAPSULES 40MG
Registration Code
HK-67999
Company Name
ELI LILLY ASIA, INC.
Company Detail Path
/organization/eli-lilly-asia-inc
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2023-10-30
Company Address
RM 3203-06 32/F, CHUBB TOWER WINDSOR HOUSE, 311 GLOUCESTER ROAD, CAUSEWAY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
33ff326f6ab0bc04
Type
Standard
Back to PPB Approvals